Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cara Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CARA
Nasdaq
8731
https://www.caratherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cara Therapeutics Inc
Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 11:00 am
Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
- Mar 7th, 2024 12:00 pm
7 F-Rated Stocks to Sell in March 2024
- Mar 7th, 2024 11:40 am
Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report
- Mar 7th, 2024 10:47 am
Cara Therapeutics Full Year 2023 Earnings: Misses Expectations
- Mar 6th, 2024 10:35 am
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
- Mar 5th, 2024 2:07 pm
Q4 2023 Cara Therapeutics Inc Earnings Call
- Mar 5th, 2024 12:51 pm
Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
- Mar 4th, 2024 10:10 pm
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
- Mar 4th, 2024 9:01 pm
We're A Little Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate
- Feb 21st, 2024 3:05 pm
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
- Feb 12th, 2024 9:01 pm
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
- Jan 22nd, 2024 12:00 pm
CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
- Dec 19th, 2023 4:55 pm
Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
- Dec 18th, 2023 12:00 pm
Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript
- Nov 14th, 2023 4:04 pm
Q3 2023 Cara Therapeutics Inc Earnings Call
- Nov 14th, 2023 1:48 pm
Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say
- Nov 13th, 2023 11:00 pm
Cara Therapeutics Reports Third Quarter 2023 Financial Results
- Nov 13th, 2023 9:01 pm
These Biotech Stocks Could Double Your Money, According To Analysts
- Nov 9th, 2023 4:38 pm
Pliant Therapeutics, Inc. (PLRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
- Nov 7th, 2023 3:00 pm
Scroll